Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Friday broker round-up
Fri, 26th Jun 2015 10:11
ARM Holdings: Bernstein downgrades to underperform.GlaxoSmithKline: Liberum ups view to hold from sell. HSBC initiates coverage at buy with 1,700p target.AztraZeneca: HSBC initiates coverage at hold with 4,640p target.Qinetiq: UBS downgrades to sell from neutral.Meggitt: UBS raises view to neutral from sell.Petrofac: Deutsche Bank downgrades to sell from hold.Kingfisher: Davy initiates coverage at underperform.
Astrazeneca 
Kingfisher 
Qinetiq 
Glaxosmithkline
Astrazeneca Kingfisher Qinetiq Glaxosmithkline Shares in this article
Latest News
- HSBC partners with Google Cloud to expand AI usage
5 hours ago - Potential Tropical Cyclone One forms off Texas coast, threatening dangerous flash flooding
5 hours ago - UK secures $1.7 billion in investments from Indian, French companies at G7
5 hours ago - US close: Dow notches another record close, chip stocks weigh on Nasdaq
6 hours ago - UK PM Starmer unveils GBP1 billion French and Indian investments at G7
6 hours ago - DIRECTOR DEALINGS: Rathbones Chair & CEO pick up shares after warning
7 hours ago - Russian frigate fires warning shots near UK waters to avert yacht collision
8 hours ago
Related News
18 hours ago
WINNERS & LOSERS: SDCL drops dividend; Rathbones pauses some inflows
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday.
ConvaTec
20 hours ago
LONDON BROKER RATINGS: RBC cuts Frasers and raises Currys
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
AB Foods
1 day ago
AstraZeneca's Ultomiris wins US FDA priority review in kidney disease
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologic...
Follow the stocks
